Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET)
- PMID: 15971355
- DOI: 10.1177/08830738050200050701
Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET)
Abstract
Tuberous sclerosis complex is commonly associated with medically intractable seizures. We previously demonstrated that high uptake of alpha-[11C]methyl-L-tryptophan (AMT) on positron emission tomography (PET) occurs in a subset of epileptogenic tubers consistent with the location of seizure focus. In the present study, we analyzed the surgical outcome of children with tuberous sclerosis complex in relation to AMT PET results. Seventeen children (mean age 4.7 years) underwent epilepsy surgery, guided by long-term videoelectroencephalography (EEG) (including intracranial EEG in 14 cases), magnetic resonance imaging (MRI), and AMT PET. AMT uptake values of cortical tubers were measured using regions of interest delineated on coregistered MRI and were divided by the value for normal-appearing cortex to obtain an AMT uptake ratio. Based on surgical outcome data, tubers showing increased AMT uptake (uptake ratio greater than 1.00) were classified into three categories: (1) epileptogenic (tubers within an EEG-defined epileptic focus whose resection resulted in seizure-free outcome), (2) nonepileptogenic (tubers that were not resected but the patient became seizure free), or (3) uncertain (all other tubers). Increased AMT uptake was found in 30 tubers of 16 children, and 23 of these tubers (77%) were located in an EEG-defined epileptic focus. The tuber with the highest uptake was located in an ictal EEG onset region in each patient. Increased AMT uptake indicated an epileptic region not suspected by scalp EEG in four cases. Twelve children (71%) achieved seizure-free outcome (median follow-up 15 months). Based on outcome criteria, 19 of 30 tubers (63%) with increased AMT uptake were epileptogenic, and these tubers had significantly higher AMT uptake than the nonepileptogenic ones (P = .009). Tubers with at least 10% increase of AMT uptake (in nine patients) were all epileptogenic. Using a cutoff threshold of 1.02 for AMT uptake ratio provided an optimal accuracy of 83% for detecting tubers that needed to be resected to achieve a seizure-free outcome. The findings suggest that resection of tubers with increased AMT uptake is highly desirable to achieve seizure-free surgical outcome in children with tuberous sclerosis complex and intractable epilepsy. AMT PET can provide independent complementary information regarding the localization of epileptogenic regions in tuberous sclerosis complex and enhance the confidence of patient selection for successful epilepsy surgery.
Comment in
-
Seeing with new eyes: using positron emission tomography (PET) to identify epileptogenic tubers.J Child Neurol. 2005 May;20(5):399. doi: 10.1177/08830738050200051901. J Child Neurol. 2005. PMID: 15968922 No abstract available.
Similar articles
-
A distinct microRNA expression profile is associated with α[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex.Neurobiol Dis. 2018 Jan;109(Pt A):76-87. doi: 10.1016/j.nbd.2017.10.004. Epub 2017 Oct 7. Neurobiol Dis. 2018. PMID: 28993242 Free PMC article.
-
Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography.Ann Neurol. 1998 Dec;44(6):858-66. doi: 10.1002/ana.410440603. Ann Neurol. 1998. PMID: 9851429
-
Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy.Epilepsia. 2013 Dec;54(12):2143-50. doi: 10.1111/epi.12412. Epub 2013 Oct 28. Epilepsia. 2013. PMID: 24304437
-
α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.Biomark Med. 2011 Oct;5(5):577-84. doi: 10.2217/bmm.11.68. Biomark Med. 2011. PMID: 22003906 Free PMC article. Review.
-
Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex.Neuropediatrics. 2002 Oct;33(5):255-61. doi: 10.1055/s-2002-36740. Neuropediatrics. 2002. PMID: 12536368 Review.
Cited by
-
Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy.Epilepsia. 2011 Sep;52(9):1692-8. doi: 10.1111/j.1528-1167.2011.03103.x. Epub 2011 May 13. Epilepsia. 2011. PMID: 21569023 Free PMC article.
-
Epilepsy surgery: eligibility criteria and presurgical evaluation.Dialogues Clin Neurosci. 2008;10(1):91-103. doi: 10.31887/DCNS.2008.10.1/pryvlin. Dialogues Clin Neurosci. 2008. PMID: 18472487 Free PMC article. Review.
-
Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.J Neurooncol. 2012 Apr;107(2):365-72. doi: 10.1007/s11060-011-0750-y. Epub 2011 Nov 3. J Neurooncol. 2012. PMID: 22048879 Free PMC article.
-
A distinct microRNA expression profile is associated with α[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex.Neurobiol Dis. 2018 Jan;109(Pt A):76-87. doi: 10.1016/j.nbd.2017.10.004. Epub 2017 Oct 7. Neurobiol Dis. 2018. PMID: 28993242 Free PMC article.
-
Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy.Childs Nerv Syst. 2006 Aug;22(8):810-20. doi: 10.1007/s00381-006-0137-0. Epub 2006 Jun 24. Childs Nerv Syst. 2006. PMID: 16799821 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical